SRPT

#1698
Sarepta Therapeutics, Inc. - Common Stock
17.8 7 USD
+3.24%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
17.87
17.87
Rango anual
10.41
43.91
Cambio diario
+3.24%
Variación mensual
-14.78%
Variación en los últimos 6 meses
-14.74%
Cambio anual
-53.04%
Cierres anteriores
17.3 1
Open
17.8 7
Mínimo
17.8 7
High
17.8 7
Volumen
188
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.89 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-22.67
Relación precio/flujo de caja
1.08

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

Noticias